Biotech News
-
- Miami, Business, Finance, Medical, Health, Marketing, Media, Healthcare, Biotech, Stocks, Stock Market, Financial, Nasdaq
Commercial Sales Launch Following FDA Approval; National Sales Force Now in Action as January Shipments and Major Market Opportunity Take Shape
-
OncoBeta Introduces Rhenium-SCT for Non-Melanoma Skin Cancer at Theageneio Cancer Hospital of Thessaloniki
-
New Patient Data Show REQORSA® Activating Cellular Repair Pathways as Roche Collaboration Advances Precision Lung Cancer Strategy for Genprex, Inc
- New TROP2 Research Breakthrough Strengthens REQORSA® Gene Therapy Story as Roche Collaboration Advances Precision Lung Cancer Treatment: Genprex, Inc
- Miami, Business, Finance, Medical, Health, Marketing, Media, Healthcare, Biotech, Stocks, Stock Market, Financial, NasdaqFDA Approval; Major Milestone for Preservative-Free Ketamine Ahead of FDA Goal Date for Treatment of Suicidal Depression by NRx Pharmaceuticals, Inc
- Miami, Business, Finance, Medical, Health, Marketing, Media, Healthcare, Biotech, Stocks, Stock Market, Financial, NasdaqMajor FDA Victory; Preservative-Free Ketamine Approved Ahead of November 10 Goal Date as Commercial Launch Opportunity Comes Into Focus for NRx Pharma
-
New Research Spotlight, Expanding TUSC2 Science & Strategic Development Milestones Put Gene Therapy Innovation into Focus for Genprex (NAS DAQ: GNPX)
-
Expanding Into Medically Supervised Wellness With Major Apollo Wellness Centers Announcement; Sibannac, Inc. (Stock Symbol: SNNC)
- Miami, Business, Finance, Medical, Health, Marketing, Media, Healthcare, Biotech, Stocks, Stock Market, Financial, Nasdaq
Commercial Manufacturing Validation Completed as November 10 FDA Milestone Approaches; Critical FDA Milestone Close: NRx Pharmaceuticals NAS DAQ: NRXP
- Miami, Business, Finance, Medical, Health, Marketing, Media, Healthcare, Biotech, Stocks, Stock Market, Financial, NasdaqCritical FDA Milestone much Closer as Preservative-Free Ketamine Review Advances: NRx Pharmaceuticals (N A S D A Q: NRXP)
-
ClearSight Therapeutics Receives U.S. Patent Notice of Allowance
- Miami, Business, Finance, Medical, Health, Marketing, Media, Healthcare, Biotech, Stocks, Stock Market, Financial, Nasdaq$11.18 Million DARPA Award Ignites a Major New Catalyst as FDA, Robotic TMS and Commercialization Milestones Converge for NRx Pharmaceuticals, Inc
-
Nutriband (N A S D A Q: NTRB): Fighting Back Against the Fentanyl Crisis With a New Approach to Safer Transdermal Medicines
-
Retatrutide Research Suppliers Compared in 2026: COAs, Testing, Pricing and What Labs Should Check
- Nutriband Inc. (N A S D A Q: NTRB) Breaks Into Uncharted Territory: 52-Week High Eclipsed as Shares Surge 22% —AVERSA™ Puts Investors on High Alert
- Warrant Activity, AVERSA™ Progress and a Potentially Transformative Fall Take Center Stage: Nutriband Inc. (N A S D A Q: NTRB)
-
Building a Diversified Healthcare Platform as Exosome Science, Telehealth, Diagnostics & Strategic Acquisitions Converge: NexTel Medical (OTCID: MAJI)
- Miami, Business, Finance, Medical, Health, Marketing, Media, Healthcare, Biotech, Stocks, Stock Market, Financial, NasdaqEuropean Patent for ALS Program Expands the Story: HOPE Deploys Robotic TMS & FDA Commercialization Path Advances: NRx Pharmaceuticals: NAS DAQ: NRXP
- Miami, Business, Finance, Medical, Health, Marketing, Media, Healthcare, Biotech, Stocks, Financial, NasdaqFDA-Cleared Zeta TMS Robotic System Moves Toward Deployment as FDA, DARPA and Commercial Catalysts Converge: NRx Pharmaceuticals (N A S D A Q: NRXP)
- Miami, Business, Finance, Medical, Health, Marketing, Media, Healthcare, Biotech, Stocks, Financial, NasdaqFDA Path Clears, Manufacturing Ramps Up + $22.3 Million Strengthens the Balance Sheet; Inflection Point for NRx Pharmaceuticals (N A S D A Q: NRXP)
TCA VG: 2025 Funding Climbs to $9M across 43 Companies; Cumulative Returns Reach 5.3 MOIC & 22% IRR